Ear Health Market

Ear Health Market by Product (Ear Health Devices (Diagnostic Devices, Surgical Devices, Hearing Aids, Hearing Implants, CO2 Lasers), Ear Health Supplements, Ear Infection Drug Treatment), and Region - Global Forecast to 2026

Report Code: PH 8019 Dec, 2021, by marketsandmarkets.com

[78 Pages Report] The global ear health market is projected to reach USD 1.9 billion by 2026 from USD 1.4 billion in 2021, at a CAGR of 6.3% during the forecast period. Growth in this market is largely driven by the growing geriatric population, high prevalence of ear diseases, rising incidence of noise-induced hearing loss, and shift in consumer preference towards plant-based supplements. Moreover, untapped emerging markets in developing countries are creating lucrative opportunities for the market players.

To know about the assumptions considered for the study, Request for Free Sample Report

Ear health Market Dynamics

Drivers: High prevalence of ear diseases

According to WHO estimates, globally, more than 466 million people have disabling hearing loss, and ear infections are the leading cause of it. Of this, around 432 million (93% of this population) are adults (242 million males and 190 million females) and 34 million (7% of this population) are children. Approximately one-third of the population aged over 65 years is impacted by disabling hearing loss. These trends are projected to drive the demand for otoscopes, as these instruments are widely used for diagnosing ear-related disorders. The U.S. Centers for Disease Control and Prevention (CDC) estimates that nearly 15% (over 50 million people) of Americans experience some form of tinnitus. The rising prevalence of ear diseases is expected to drive the adoption of ear health devices/drugs/supplements in the market.

Restraints: Adverse effects of ear health supplements

The supplements that claim to be effective on tinnitus and hearing impairment often do not work positively for every patient. These supplements are not proven to work and are filled with ingredients that often have little to no tinnitus-related research behind them. The ingredients themselves are not proprietary in any way. However, dietary supplement companies can claim that the specific ratio of included ingredients—their formula—is proprietary. The use of these supplements also causes side-effects in many patients. For instance, Gingko biloba, a traditional medicine used as an ingredient in a majority of ear health supplements, causes side effects such as nausea, vomiting, and headaches. It can also cause severe bleeding in people who take blood thinners or have blood-clotting disorders.

Opportunities: Emerging markets offer lucrative opportunities

Emerging economies such as India, South Korea, Malaysia, Vietnam, Saudi Arabia, and the UAE offer significant growth opportunities to major market players. This can be attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure. In addition, the regulatory policies in the Asia Pacific region are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn key players in the ear health market to focus on emerging countries.

Challenges: Shortage of trained professionals

Currently, several countries are facing a shortage of skilled professionals who are capable of effectively performing ear surgery procedures, such as cochlear implantation. In 2012, there were 8,600 otolaryngologists in the US, and it is estimated that there will be a shortage of 2,500 otolaryngologists in the country by 2025 (Source: PubMed.gov). In 2020, in Canada, there were approximately 715 otorhinolaryngology surgeons, reflecting two surgeons per 100,000 people (Source: Journal of Medicine in the Tropics). Similarly, according to a survey of ENT services in Sub-Saharan Africa (2017 Survey), the total population of the 22 countries represented in the study (in sub-Saharan Africa) was 720,500,000 (75% of the population of Sub-Saharan Africa). The dearth of skilled ENT surgeons in these countries is expected to limit the number of surgical procedures performed, including cochlear implantation, despite the presence of a large target patient population base. This is a major challenge for the growth of the ear health market.

Ear health devices was the largest segment in the product of ear health market in 2020

Ear health devices accounted for the largest share of ear health market in 2020.

APAC to witness the highest growth rate during the forecast period.M

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by the growing geriatric population, and high prevalence of ear diseases. Emerging markets offer significant and attractive growth opportunities for ear health market. The growth of ENT clinics & hospitals in these countries has increased the demand for ear health products.

Ear Health Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The products and services market is dominated by a few globally established players such as include Sonova Holdings AG (Switzerland), Olympus Corp. (Japan), William Demant Holdings A/S (Denmark), Cochlear Limited (Australia), and Stryker Corporation (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Million (USD)

Segments covered

Product, device type, and region.

Geographies covered

North America, Europe, Asia Pacific, Latin America, and Middle East and Africa

Companies covered

Sonova Holdings AG (Switzerland), Olympus Corp. (Japan), William Demant Holdings A/S (Denmark), Cochlear Limited (Australia), Stryker Corporation (US), Johnson & Johnson (US), Novartis (Switzerland), Karl Storz GMBH & Co. KG (Germany), Medtronic Plc (Ireland), Oscar Remedies Pvt Ltd. (India), and InnerScope Hearing Technologies (US).

The study categorizes the ear health market based on product, device type at global level.

Global Ear Health Market, by Product

  • Ear health Market, By Product
    •  Ear Health devices
      • Diagnostic Devices
      • Surgical Devices
      • Hearing Aids
      • Hearing Implants
      • CO2 Lasers
      • Image-guided Surgery Systems         
    • Tinnitus and ear impairment care supplements
    • Ear infection treatment medication

Global Ear health Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In 2021, Sonova Holding AG (Switzerland) acquired Sennheiser (Germany) for expanding its offerings and entering new growth markets.
  • In 2021, Medtronic PLC (Ireland) acquired Intersect ENT (US) to expand Medtronic's portfolio of products used during ear, nose, and throat procedures.
  • In 2021, InnerScope Hearing Technologies (US) acquired Atlazo Inc. (US) for developing next-generation hearing aids and hearable products by utilizing Atlazo’s patented Artificial Intelligence (AI) hardware platform.
  • In 2020, Karl Storz GMBH & Co. KG (Germany) installed six OFFICE1 examination rooms specialized for ENT treatment at the IPS Central Hospital in Asunción, Paraguay.

Frequently asked questions

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

    TABLE OF CONTENTS

    1 INTRODUCTION (Page No. - 12)
        1.1 OBJECTIVES OF THE STUDY
        1.2 MARKET DEFINITION
               1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
               1.2.2 MARKETS COVERED
                        FIGURE 1 EAR HEALTH MARKET
               1.2.3 YEARS CONSIDERED FOR THE STUDY
        1.3 CURRENCY
        1.4 LIMITATIONS
        1.5 STAKEHOLDERS

    2 MARKET OVERVIEW (Page No. - 15)
        2.1 INTRODUCTION
        2.2 MARKET DYNAMICS
              FIGURE 2 EAR HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
               2.2.1 DRIVERS
                        2.2.1.1 High prevalence of ear diseases
                                    TABLE 1 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP (10-YEAR RANGE)
                        2.2.1.2 Growth in the geriatric population
                                    FIGURE 3 SHARE OF THE GLOBAL POPULATION AGED 65 AND ABOVE (2015–2019)
                        2.2.1.3 Rising incidence of noise-induced hearing loss
                        2.2.1.4 Shift in consumer preference toward plant-based supplements
               2.2.2 RESTRAINTS
                        2.2.2.1 High cost of ear health devices and supplements
                        2.2.2.2 Adverse effects of ear health supplements
               2.2.3 OPPORTUNITIES
                        2.2.3.1 Emerging markets offer lucrative opportunities
               2.2.4 CHALLENGES
                        2.2.4.1 Shortage of trained professionals
                        2.2.4.2 Consumer skepticism associated with ear nutraceuticals

    3 EAR HEALTH MARKET, BY PRODUCT (Page No. - 20)
        3.1 INTRODUCTION
              TABLE 2 GLOBAL EAR HEALTH MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
        3.2 EAR HEALTH DEVICES
              TABLE 3 GLOBAL EAR HEALTH DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
              TABLE 4 GLOBAL EAR HEALTH DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
               3.2.1 DIAGNOSTIC DEVICES
                        TABLE 5 COMMON CAUSES OF HEARING LOSS AND DEAFNESS
                        TABLE 6 GLOBAL DIAGNOSTIC DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
               3.2.2 SURGICAL DEVICES
                        TABLE 7 US: NUMBER OF OTOPLASTY PROCEDURES (2017-2020)
                        TABLE 8 GLOBAL SURGICAL DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
               3.2.3 HEARING AIDS
                        TABLE 9 GLOBAL HEARING AIDS MARKET, BY REGION, 2019–2026 (USD MILLION)
               3.2.4 HEARING IMPLANTS
                        TABLE 10 GLOBAL HEARING IMPLANTS MARKET, BY REGION, 2019–2026 (USD MILLION)
               3.2.5 CO2 LASERS
                        TABLE 11 GLOBAL CO2 LASERS MARKET, BY REGION, 2019–2026 (USD MILLION)
               3.2.6 IMAGE-GUIDED SURGERY SYSTEMS
                        TABLE 12 GLOBAL IMAGE-GUIDED SURGERY SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
        3.3 TINNITUS AND EAR IMPAIRMENT CARE SUPPLEMENTS
              TABLE 13 GLOBAL TINNITUS AND EAR IMPAIRMENT CARE SUPPLEMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
        3.4 EAR INFECTION TREATMENT MEDICATION
              TABLE 14 GLOBAL EAR INFECTION TREATMENT MEDICATION MARKET, BY REGION, 2019–2026 (USD MILLION)

    4 EAR HEALTH MARKET, BY REGION (Page No. - 30)
        4.1 INTRODUCTION
              TABLE 15 GLOBAL EAR HEALTH MARKET, BY REGION, 2019–2026 (USD MILLION)
        4.2 NORTH AMERICA
              TABLE 16 NORTH AMERICA: EAR HEALTH MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
              TABLE 17 NORTH AMERICA: EAR HEALTH DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
        4.3 EUROPE
              TABLE 18 EUROPE: EAR HEALTH MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
              TABLE 19 EUROPE: EAR HEALTH DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
        4.4 ASIA PACIFIC
              TABLE 20 ASIA PACIFIC: EAR HEALTH MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
              TABLE 21 ASIA PACIFIC: EAR HEALTH DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
        4.5 LATIN AMERICA
              TABLE 22 NUMBER OF PEOPLE WITH DISABLING HEARING LOSS IN BRAZIL AND MEXICO, 2008 VS. 2018 (MILLION)
              TABLE 23 LATIN AMERICA: EAR HEALTH MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
              TABLE 24 LATIN AMERICA: EAR HEALTH DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
        4.6 MIDDLE EAST & AFRICA
              TABLE 25 MIDDLE EAST & AFRICA: EAR HEALTH MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
              TABLE 26 MIDDLE EAST & AFRICA: EAR HEALTH DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)

    5 COMPETITIVE LANDSCAPE (Page No. - 38)
        5.1 OVERVIEW
              FIGURE 4 KEY DEVELOPMENTS IN THE EAR HEALTH MARKET, JANUARY 2018–NOVEMBER 2021
        5.2 RANKING OF KEY PLAYERS IN THE EAR HEALTH MARKET
              FIGURE 5 EAR HEALTH MARKET: MARKET RANK OF KEY PLAYERS

    6 COMPANY PROFILES (Page No. - 40)
        6.1 KEY PLAYERS
    (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
               6.1.1 SONOVA HOLDING AG
                        FIGURE 6 SONOVA HOLDING AG: COMPANY SNAPSHOT
                        TABLE 27 SONOVA HOLDING AG: BUSINESS OVERVIEW
               6.1.2 OLYMPUS CORPORATION
                        FIGURE 7 OLYMPUS CORPORATION: COMPANY SNAPSHOT
                        TABLE 28 OLYMPUS CORPORATION: BUSINESS OVERVIEW
               6.1.3 WILLIAM DEMANT HOLDING A/S
                        FIGURE 8 WILLIAM DEMANT HOLDING A/S: COMPANY SNAPSHOT
                        TABLE 29 WILLIAM DEMANT HOLDING A/S: BUSINESS OVERVIEW
               6.1.4 STRYKER CORPORATION
                        FIGURE 9 STRYKER CORPORATION: COMPANY SNAPSHOT
                        TABLE 30 STRYKER CORPORATION: BUSINESS OVERVIEW
               6.1.5 COCHLEAR LIMITED
                        FIGURE 10 COCHLEAR LIMITED: COMPANY SNAPSHOT
                        TABLE 31 COCHLEAR LIMITED: BUSINESS OVERVIEW
               6.1.6 JOHNSON & JOHNSON
                        FIGURE 11 JOHNSON & JOHNSON: COMPANY SNAPSHOT
                        TABLE 32 JOHNSON & JOHNSON: BUSINESS OVERVIEW
               6.1.7 NOVARTIS
                        FIGURE 12 NOVARTIS: COMPANY SNAPSHOT
                        TABLE 33 NOVARTIS: BUSINESS OVERVIEW
               6.1.8 KARL STORZ GMBH & CO. KG
                        TABLE 34 KARL STORZ GMBH & CO. KG: BUSINESS OVERVIEW
               6.1.9 MEDTRONIC PLC
                        FIGURE 13 MEDTRONIC PLC: COMPANY SNAPSHOT
                        TABLE 35 MEDTRONIC PLC: BUSINESS OVERVIEW
               6.1.10 OSCAR REMEDIES PVT. LTD.
                         TABLE 36 OSCAR REMEDIES: BUSINESS OVERVIEW
               6.1.11 INNERSCOPE HEARING TECHNOLOGIES, INC.
                         TABLE 37 INNERSCOPE HEARING TECHNOLOGIES, INC.: BUSINESS OVERVIEW
               6.1.12 ARCHES NATURAL PRODUCTS, INC.
                         TABLE 38 ARCHES NATURAL PRODUCTS, INC.: BUSINESS OVERVIEW
               6.1.13 PHYTAGE LABS
                         TABLE 39 PHYTAGE LABS: BUSINESS OVERVIEW
               6.1.14 THE RELIEF PRODUCTS, INC.
                        TABLE 40 THE RELIEF PRODUCTS, INC.: BUSINESS OVERVIEW

    *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

    This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

    Secondary Research

    This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global ear health market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the ear health market. The primary sources from the demand side include otolaryngologists, research professionals, academic leaders.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, device type, and region).

    Data Triangulation

    After arriving at the market size, the total Ear health market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

    Report Objectives

    • To define, describe, and forecast the ear health market by product and region
    • To provide detailed information about the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To forecast the size of the ear health market in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and comprehensively analyze their core competencies in the ear health market
    • To track and analyze competitive developments such as partnerships, agreements, collaborations, mergers & acquisitions, and product launches in the ear health market

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Asia Pacific Ear health Market into Australia, New Zealand and others
    • Further breakdown of the Rest of Europe Ear health Market into The Netherlands, Belgium, Switzerland and others
    • Further breakdown of the Latin America Ear health Market into Argentina, Colombia, Chile, and others
    Custom Market Research Services

    We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

    Request Customization

    Instant Answers with GPT - Ask Now!

    Ask real questions. Get complete answers !
    Report Code
    PH 8019
    Published ON
    Dec, 2021
    Choose License Type
    BUY NOW
    • SHARE
    X
    Request Customization
    Speak to Analyst
    Speak to Analyst
    OR FACE-TO-FACE MEETING
    PERSONALIZE THIS RESEARCH
    • Triangulate with your Own Data
    • Get Data as per your Format and Definition
    • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
    • Any level of Personalization
    REQUEST A FREE CUSTOMIZATION
    LET US HELP YOU!
    • What are the Known and Unknown Adjacencies Impacting the Ear Health Market
    • What will your New Revenue Sources be?
    • Who will be your Top Customer; what will make them switch?
    • Defend your Market Share or Win Competitors
    • Get a Scorecard for Target Partners
    CUSTOMIZED WORKSHOP REQUEST
    +1-888-600-6441
    • Call Us
    • +1-888-600-6441 (Corporate office hours)
    • +1-888-600-6441 (US/Can toll free)
    • +44-800-368-9399 (UK office hours)
    CONNECT WITH US
    ABOUT TRUST ONLINE
    ©2024 MarketsandMarkets Research Private Ltd. All rights reserved
    DMCA.com Protection Status Website Feedback